Credence Research Inc. has released a new study on the Blood Glucose Monitoring Devices Market. According the report the ...
Indoor plants are notoriously tricky to keep healthy and alive, especially in winter. You're attempting to replicate a complex and naturally accommodating biome inside your home. Plants that thrive in ...
Hypertension is the leading risk factor for cardiovascular disease, the most common cause of death worldwide. Less than half the people with high blood pressure are aware of their diagnosis, and only ...
Dexcom reports 13% Q4 revenue growth to $1.26B, beating analyst expectations despite mixed analyst ratings and competitive pressures.
New CEO Jake Leach said the company plans a trial readout in mid-2026 to support coverage of its glucose sensors in Type 2 users who don’t take insulin.
StockStory.org on MSN
DXCM Q4 deep dive: New product launches and international strategy drive outlook
Medical device company DexCom (NASDAQ:DXCM) reported Q4 CY2025 results , with sales up 13.1% year on year to $1.26 billion. The company expects the full year’s revenue to be around $5.21 billion, ...
Q4 2025 Earnings Call February 12, 2026 4:30 PM ESTCompany ParticipantsSean Christensen - Vice President of Finance and ...
In general, as someone without diabetes, you want your fasting blood sugar (when you haven’t eaten for at least eight hours) to be below 100 mg/dL. You want your spikes to be below 180 mg/dL, to lower ...
Abbott (NYSE:ABT) is facing an FDA warning letter alleging quality system regulation violations related to FreeStyle Libre ...
Better late than never, right? Look, we know it’s late January. Most people have already abandoned their New Year’s resolutions, and the wearables world is already whispering about what’s coming later ...
What if upgrading your home with smart technology didn’t have to cost a fortune? A Smarter House takes a closer look at how IKEA’s new smart home lineup is reshaping the market by offering affordable, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results